Oxidized LDL activates STAT1 and STAT3 transcription factors: possible involvement of reactive oxygen species  by Mazière, Cécile et al.
Oxidized LDL activates STAT1 and STAT3 transcription factors:
possible involvement of reactive oxygen species
CeŁcile MazieØre*, Gulie Alimardani, Franc°oise Dantin, Franc°oise Dubois, Marie-Alix Conte,
Jean-Claude MazieØre
Laboratoire de Biochimie, CHRU Amiens, HoŒpital Nord, 80054 Amiens Cedex 01, France
Received 23 February 1999
Abstract The effect of cupric ion-oxidized low density lipopro-
tein (Cu-LDL) or endothelial cell-oxidized LDL (E-LDL) on
STAT1 and STAT3 (signal transducers and activators of
transcription) DNA binding activity was investigated by electro-
phoretic mobility shift assay in human endothelial cells. Both
oxidized LDL enhanced STAT1 and STAT3 binding to their
respective consensus binding sites. Furthermore, the activation of
STATs was proportional to the oxidation degree of LDL in that
the highly oxidized Cu-LDL exhibited a more marked effect than
E-LDL. Oxidized LDL induced an intracellular oxidative stress,
as shown by the increase in the intracellular level of lipid
peroxidation products (thiobarbituric acid-reactive substances)
and in the level of reactive oxygen species, measured by the
fluorescence of dichlorofluorescein diacetate. The binding
activity of STAT1 and STAT3 paralleled these two parameters,
which suggests that it is dependent upon the redox state of the
cell. The activation of STATs by oxidized LDL was almost
completely inhibited by the lipophilic antioxidant vitamin E, and
partially antagonized by the hydrophilic thiol-containing com-
pound N-acetylcysteine, suggesting that the oxidative stress
induced by oxidized LDL is involved in the observed phenom-
enon. Furthermore, the lipid extract of Cu-LDL also activated
STAT1 and STAT3. Since the STAT pathway plays a key role
in cytokine and growth factor signal transduction, the activation
of STATs by oxidized LDL might be related to their
proinflammatory and fibroproliferative effect in the athero-
sclerotic plaque.
z 1999 Federation of European Biochemical Societies.
Key words: Signal transducer and activator of transcription;
Oxidized low density lipoprotein; Atherosclerosis
1. Introduction
It is recognized that oxidatively modi¢ed low density lip-
oproteins (LDL) play an important role in the generation and
progression of the atherosclerotic plaque (review in [1]). Oxi-
dative modi¢cation of LDL can be achieved by incubation
with cultured cells such as monocytes [2] or endothelial cells
[3]. In vitro incubation of the LDL particle with transition
metals such as copper can also initiate LDL oxidation [4].
The oxidative modi¢cation of LDL involves the generation
of lipid peroxidation products such as aldehydes [5] and hy-
droperoxides [6]. Oxidized LDL induce the secretion of in-
£ammatory cytokines such as interleukin-1 (IL1) [7] and tu-
mor necrosis factor-K [8] by the activated macrophages
present in the atherosclerotic lesions, or the secretion of
growth factors such as PDGF [9].
Many cytokines and growth factors mediate their e¡ects via
the activation of a common signal transduction pathway, the
JAK/STAT pathway (review in [10]). The binding of the
ligand to its speci¢c membrane receptor results in receptor
aggregation, which leads to the catalytic activation of recep-
tor-associated cytoplasmic protein tyrosine kinase termed Ja-
nus kinases (JAKs), that mediate ligand-dependent receptor
phosphorylation. Receptor phosphotyrosyl residues are in
turn recognized by the SH2 domains of the STAT family of
cytoplasmic transcription factors [11,12]. The STAT factors
are then activated by tyrosine phosphorylation [13,14] fol-
lowed by dimerization [15], which is a prerequisite for trans-
port to the nucleus, DNA binding and subsequent transcrip-
tional activity [16,17].
This study was undertaken to investigate whether the LDL
oxidatively modi¢ed by endothelial cells or by copper ions can
regulate the DNA binding activity of the transcription factors
STAT1 and STAT3. It was found that both oxidized LDL
stimulated STAT binding activity in endothelial cells, ¢bro-
blasts and T lymphocytes. The degree of STAT activation by
oxidized LDL appeared to be proportional to the intracellular
oxidative stress, as quantitated by the level of lipid peroxida-
tion products and reactive oxygen species.
2. Materials and methods
2.1. Materials
Ham F10 medium, Dulbecco’s minimum essential medium
(DMEM) and fetal calf serum were from Gibco (Grand Island, NY,
USA). The oligonucleotide probes STAT1 (5P-CAT GTT ATG CAT
ATT CCT GTA AGT G-3P) and STAT3 (5P-GAT CCT TCT GGG
AAT TCC TAG ATC-3P) consensus binding sites were synthesized by
Eurogentec (Belgium). [Q-32P]ATP 7000 Ci/mmol was from ICN (CA,
USA). Dichloro£uorescein diacetate was purchased from Molecular
Probes. All other chemicals were of Sigma grade.
2.2. Cell culture
The ECV 304 human endothelial cell line was purchased from the
European Collection of Cell Cultures. The cells were maintained in
Ham’s F10 medium supplemented with 10% fetal calf serum, at 37‡C
under a 5% C02 humidi¢ed atmosphere. All experiments were per-
formed on subcon£uent cultures.
2.3. LDL preparation and oxidation
LDL (d 1.024^1.050) was prepared from normal human serum by
sequential ultracentrifugation according to Havel et al. [18], and dia-
lyzed against 0.005 M Tris, 0.05 M NaCl, 0.02% EDTA pH 7.4 for
conservation. Prior to oxidation, EDTA was removed by dialysis.
Oxidation was performed by incubation at 37‡C of 1 mg LDL pro-
tein/ml with 5U1036 M CuSO4 or of 0.1 mg LDL protein/ml with
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ECV 304 endothelial cells for 24 h in Ham’s F10 medium. Control
LDL was incubated at 37‡C for 24 h. The degree of LDL oxidation
was checked by determination of thiobarbituric acid-reactive substan-
ces (TBARS) according to Yagi [19] and by determination of the
electrophoretic mobility of the LDL particle. The lipid extracts of
control or Cu-LDL were prepared by the method of Bligh and
Dyer [20].
2.4. Preparation of nuclear extracts
All experiments were performed on subcon£uent cultures, 3 days
after seeding. The cells were preincubated for 24 h in medium devoid
of serum and supplemented with 0.1% bovine serum albumin. The
cells were then incubated with 0.05 mg control or oxidized LDL
protein/ml for 4 h. In some experiments, the lipid extract of Cu2-
oxidized LDL at a concentration equivalent to 0.05 mg LDL protein/
ml was introduced in ethanol solution (¢nal concentration 0.3% v/v)
during 4 h. Nuclear extracts were then prepared according to Dignam
et al. [21]. The cells were resuspended in 10 mM HEPES, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT, 0.1% Nonidet P40 and the pro-
tease inhibitors PMSF 0.2 mM, aprotinin 2 mM, antipain, pepstatin,
benzamidine and leupeptin 1 Wg/ml. After homogenization with a
Dounce homogenizer and a 10 min incubation at 4‡C, nuclei were
collected by centrifugation at 2000Ug for 30 min. The pellet was
resuspended in 20 mM HEPES pH 7.9, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 25% glycerol and the above
antiproteases. The nuclear proteins were extracted by incubation at
4‡C during 30 min. After centrifugation at 13 000Ug for 15 min, the
supernatant was kept at 380‡C.
2.5. Electrophoretic mobility shift assay
The double stranded oligonucleotides were end-labeled using T4
kinase and [Q-32P]ATP. 7 Wg of nuclear extract was incubated with
100 000 dpm of labeled probe (0.5 ng) in the presence of 1 Wg of
poly(dIdC) at room temperature for 20 min followed by separation
of the mixture on a 6% non-denaturing polyacrylamide gel in Tris 50
mM/glycine 0.38 M/EDTA 2 mM bu¡er at pH 7.5. After autoradiog-
raphy, the radioactivity was quanti¢ed by liquid scintillation counting.
Results are representative of at least three independent experiments.
2.6. Quantitation of intracellular oxidation with dichloro£uorescein
diacetate
The increase in £uorescence of living cells in the presence of this
probe allows the quantitation of reactive oxygen species such as
superoxide anion, hydrogen peroxide and the hydroxyl radical [22].
Cells were preincubated in medium devoid of serum supplemented
with 0.1% bovine serum albumin for 24 h. After a 4 h incubation
with oxidized LDL (0.05 mg LDL protein/ml), the cells were incu-
bated for 30 min with 2U1036 M 2P,7P-dichloro£uorescein diacetate
in DMEM without phenol red, washed three times with phosphate
bu¡er saline and solubilized in NaOH 0.1 N. The £uorescence was
determined at 503/529 nm, normalized on a protein basis and ex-
pressed as a percentage of control.
2.7. Quantitation of intracellular lipid peroxidation products (TBARS)
After 4 h incubation with oxidized LDL as described above, the
cells were harvested and resuspended in H2O. Intracellular TBARS
were determined by the £uorometric method of Yagi [19]. Results,
normalized on a protein basis, are expressed as a percentage of con-
trol.
3. Results
We ¢rst checked the extent of LDL oxidation by copper
ions or endothelial cells by measurement of TBARS and by
determination of the relative electrophoretic mobility of the
LDL particle. Under our experimental conditions, copper ions
more extensively modi¢ed the LDL particle, in terms of both
TBARS and electrophoretic mobility as shown in Fig. 1.
The e¡ect of Cu-LDL and E-LDL was then investigated on
STAT DNA binding activity after a 4 h incubation with ECV
endothelial cells (Fig. 2). Stimulation of STAT1 and STAT3
activity was noted with both types of oxidized LDL, with a
somewhat more marked e¡ect with Cu-LDL, which led to an
approximately 3-fold activation of the STAT transcription
factors. Control LDL was very poorly e¡ective, in that only
1.1- and 1.2-fold increases were observed for STAT1 and
STAT3, respectively.
The time course study indicated that a 30 min incubation
with Cu-LDL already induced an enhancement in STAT1 and
STAT3 activity, by 1.7- and 1.8-fold respectively (Fig. 3). The
STAT1 and STAT3 binding activities increased with the in-
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Fig. 1. Characterization of control LDL (c-LDL) and copper- (Cu-
LDL) or endothelial cell-oxidized LDL (E-LDL). After EDTA re-
moval by dialysis, LDL modi¢cation was performed by a 24 h incu-
bation with CuSO4 5U1036 M (1 mg LDL protein/ml) or with en-
dothelial cells (0.1 mg LDL protein/ml) in Ham’s F10 medium at
37‡C. Control LDL was incubated in the same medium for 24 h at
37‡C. Lipid peroxidation end products (TBARS) were determined
by the technique of Yagi [19] and expressed in nmol malondialde-
hyde equivalents/mg LDL protein. The modi¢cation of the negative
net charge of LDL was assessed by agarose gel electrophoresis in a
Ciba Corning system. The results shown are from a typical experi-
ment.
Fig. 2. Autoradiogram showing the activation of STAT1 and
STAT3 by oxidized LDL. ECV 304 endothelial cells were preincu-
bated for 24 h in medium supplemented with bovine serum albumin
0.1% before addition of 0.05 mg LDL protein/ml of control or oxi-
dized LDL for 4 h. Nuclear extracts were then prepared and STAT
binding activity was determined by electrophoretic mobility shift as-
say. Left: DNA probe: STAT1 consensus binding site. Right: DNA
probe: STAT3 consensus binding site. The autoradiogram shown is
from a representative experiment. This experiment was repeated
four times with similar results.
C. MazieØre et al./FEBS Letters 448 (1999) 49^5250
cubation time and were 8- and 11-fold increased after 4 h
incubation with Cu-LDL for STAT1 and STAT3, respec-
tively. It is of note that in this experiment, the enhancement
of STAT activity was the highest ever obtained in our exper-
imental conditions. Indeed, even though the cells were prein-
cubated in medium devoid of serum during 24 h before the
addition of oxidized LDL in order to down-regulate the
STAT activity, the basal activity of the control was not always
low, as can be observed in Figs. 2 and 3. We have noticed in
the course of our experiments that the e¡ect of oxidized LDL
was more marked when the basal activity was weak, as is the
case in Fig. 3.
In order to get insight into the mechanism whereby oxidized
LDL stimulate the binding activity of STATs, we measured
the intracellular level of lipid peroxidation products (TBARS).
It was found (Table 1) that during the incubation with E-LDL
or Cu-LDL, the intracellular TBARS increased by 1.3- and
1.4-fold respectively. The e¡ect was somewhat more marked
with the extensively oxidized Cu-LDL. Similar results were
obtained when the intracellular level of reactive oxygen spe-
cies was determined by the £uorescence of dichloro£uorescein
diacetate. In this case, the values reached were 181% and
234% of control for E-LDL and Cu-LDL respectively.
The next experiment was designed to test the e¡ect of
antioxidants (vitamin E and N-acetylcysteine) on the activa-
tion of STAT1 and STAT3 by oxidized LDL. The results in
Table 2 show that the lipophilic antioxidant vitamin E almost
completely prevented the activation of STATs by Cu-LDL,
while a partial inhibition was observed with N-acetylcysteine
(about 2-fold reduction as compared to cells treated with
Cu-LDL in the absence of antioxidant). Table 2 also shows
that the lipid extract of Cu-LDL activated both STAT1
and STAT3, although to a lesser extent than the whole
particle.
4. Discussion
In the atheromatous blood vessel, the presence of T lym-
phocytes suggests that there is an in£ammatory reaction dur-
ing the generation of atherogenesis [23]. Further, during the
course of the in£ammatory process, numerous cytokines and
growth factors are involved in a paracrine or autocrine man-
ner, leading to the settlement of the ¢brous plaque [24]. The
current studies demonstrate that oxidized LDL activates
STAT1 and STAT3, the transcription factors that mediate
the e¡ect of cytokines and growth factors. Indeed, di¡erent
authors have demonstrated the stimulatory e¡ect of oxidized
LDL on the production of cytokines or growth factors [7^9],
but the action of oxidized LDL on the STAT transduction
pathway has not yet been reported. It is of note that in the
signalling of IL6-type cytokine receptors, STAT1 and STAT3
are both activated via the common signal transducer gp130,
and are able to form homo- and heterodimers [25]. In this
case, the kinases JAKs ¢rst bind to and phosphorylate the
cytoplasmic part of gp130, thereby creating docking sites for
STAT1 and STAT3. However, a number of reports demon-
strate that STAT activation might occur independently of
JAKs, via receptor tyrosine kinases such as EGF, FGF or
PDGF receptors [26,27]. In the case of oxidized LDL, whether
the activation of JAKs is involved remains to be determined.
Tyrosine phosphorylation is essential for dimerization and
DNA binding of STATs. The residues which are involved are
Tyr-701 for STAT1 [28] and Tyr-705 for STAT3 [29]. Fur-
thermore, it has also been demonstrated that the activity of
the C-terminal transactivation domain of STAT1 and STAT3
is, at least partially, regulated by a serine phosphorylation
[30,31]. The e¡ect of oxidized LDL on STAT tyrosine and
serine phosphorylation is under investigation.
It is of note that the amino acid sequence surrounding the
phosphorylated Ser-727 residue of STAT1 resembles the con-
sensus recognition sites for the MAP kinases [32,33]. Since it
has been demonstrated that oxidized LDL stimulate MAP
kinase activity in smooth muscle cells and macrophages [34],
the hypothesis of an activation of STATs by means of the
MAP kinase signalling pathway might be raised.
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Fig. 3. Time course e¡ect of Cu-LDL on STAT binding activity.
ECV 304 endothelial cells were preincubated for 24 h in medium
supplemented with bovine serum albumin 0.1% before addition of
0.05 mg Cu-LDL/ml for the indicated time. Left: DNA probe:
STAT1 consensus binding site. Right: DNA probe: STAT3 consen-
sus binding site. The autoradiogram shown is from a representative
experiment. This experiment was repeated three times with similar
results.
Table 1
E¡ect of oxidized LDL on the intracellular level of lipid peroxida-
tion products (TBARS) and of reactive oxygen species
Addition TBARS (%) Reactive oxygen species (%)
None 100 100
c-LDL 101 þ 7 99 þ 8
E-LDL 128 þ 8* 181 þ 13**
Cu-LDL 139 þ 10* 234 þ 12***
The cells were preincubated in medium devoid of serum supplemented
with 0.1% bovine serum albumin for 24 h. After 4 h incubation with
0.05 mg oxidized LDL protein/ml, the cells were resuspended in H2O
for determination of TBARS by the method of Yagi [19] (100%: 487
pmol eq MDA/mg protein). For the determination of reactive oxygen
species, the cells were incubated for 30 min with 2U1036 M 2P,7P-
dichoro£uorescein diacetate [22] in DMEM without phenol red,
washed three times with phosphate bu¡er saline and solubilized in
NaOH 0.1 N. The £uorescence was determined at 503/529 nm, nor-
malized on a protein basis and expressed in percentages of control.
Means þ S.D. of six experimental values from three independent ex-
periments. **P6 0.01, ***P6 0.001 by Student’s t-test.
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Our studies also demonstrate that oxidized LDL induced an
elevation in the level of intracellular lipid oxidation products
and of reactive oxygen species (Table 1). The lipid oxidation
products measured under our conditions might have two ori-
gins, the oxidation products included in the LDL particle
itself and those arising from the fatty acids of cellular origin.
It can be supposed that the oxidation products delivered to
the cell by oxidized LDL might generate reactive oxygen spe-
cies, which then in turn will attack the fatty acids of cellular
origin, thus propagating a chain of lipid peroxidation, and
creating oxidative stress. This hypothesis is supported by the
report of Rota et al. [35], who demonstrated that, in the
presence of cytochrome P450 or Fe2, superoxide anion and
other lipid free radicals could be formed from unsaturated
fatty acid hydroperoxides. In any case, the involvement of
the oxidized LDL lipids in the observed phenomenon is
clearly demonstrated by the activating e¡ect of the Cu-LDL
lipid extract (Table 2). Moreover, the preventive action of
antioxidants, especially that of the lipophilic compound vita-
min E, suggests that further lipid peroxidation steps triggered
by the lipid moiety of oxidized LDL and by reactive oxygen
species secondarily generated inside the cells are involved in
STATs activation.
In conclusion, the current studies suggest that the STAT
family of transcription factors are regulated by the redox state
of the cell in that they are activated by the oxidative stress
induced by oxidized LDL. This e¡ect was also found in other
cell types involved in the in£ammatory and ¢broproliferative
process observed in the atherosclerotic lesion, such as T lym-
phocytes and ¢broblasts (data not shown). The stimulation of
DNA binding activity of transcription factors by oxidized
LDL has already been reported for NF-UB [36,37] and AP1
[38]. In these reports, an involvement of the lipid peroxidation
products has also been described [37,38]. Thus, it appears that
activation of redox-sensitive transcription factors is a general
mechanism whereby oxidized LDL might act on the cellular
regulatory network. In this regard, the activation of STATs
by oxidized LDL in cells involved in the generation of the
atherosclerotic plaque might be interpreted in view of their
proin£ammatory and ¢broproliferative action on the endothe-
lial wall.
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Table 2







Cu-LDL 343 þ 27 326 þ 31
Cu-LDL+K-tocopherol 1035 M 107 þ 15 128 þ 17
Cu-LDL+N-acetylcysteine
5U1033 M
188 þ 21 166 þ 18
Lipid extract of Cu-LDL 237 þ 27 178 þ 15
The cells were preincubated with the antioxidants in medium devoid
of serum supplemented with 0.1% bovine serum albumin for 24 h.
After 4 h incubation with 0.05 mg Cu-LDL protein/ml or the lipid
extract of Cu-LDL (equivalent to 0.05 mg Cu-LDL protein/ml),
STAT binding activity was determined by electromobility shift assay.
Results are from a typical experiment. Means þ S.D. (three distinct
nuclear extracts in the same experimental set).
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